These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31107231)

  • 1. Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease.
    Mire CE; Geisbert JB; Agans KN; Versteeg KM; Deer DJ; Satterfield BA; Fenton KA; Geisbert TW
    Emerg Infect Dis; 2019 Jun; 25(6):1144-1152. PubMed ID: 31107231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.
    DeBuysscher BL; Scott D; Marzi A; Prescott J; Feldmann H
    Vaccine; 2014 May; 32(22):2637-44. PubMed ID: 24631094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.
    Mire CE; Versteeg KM; Cross RW; Agans KN; Fenton KA; Whitt MA; Geisbert TW
    Virol J; 2013 Dec; 10():353. PubMed ID: 24330654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy.
    Mire CE; Satterfield BA; Geisbert JB; Agans KN; Borisevich V; Yan L; Chan YP; Cross RW; Fenton KA; Broder CC; Geisbert TW
    Sci Rep; 2016 Aug; 6():30916. PubMed ID: 27484128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.
    Yoneda M; Georges-Courbot MC; Ikeda F; Ishii M; Nagata N; Jacquot F; Raoul H; Sato H; Kai C
    PLoS One; 2013; 8(3):e58414. PubMed ID: 23516477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease.
    Foster SL; Woolsey C; Borisevich V; Agans KN; Prasad AN; Deer DJ; Geisbert JB; Dobias NS; Fenton KA; Cross RW; Geisbert TW
    Proc Natl Acad Sci U S A; 2022 Mar; 119(12):e2200065119. PubMed ID: 35286211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease.
    Monath TP; Nichols R; Feldmann F; Griffin A; Haddock E; Callison J; Meade-White K; Okumura A; Lovaglio J; Hanley PW; Clancy CS; Shaia C; Rida W; Fusco J
    Front Immunol; 2023; 14():1216225. PubMed ID: 37731485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant vesicular stomatitis virus-vectored vaccine induces long-lasting immunity against Nipah virus disease.
    Woolsey C; Borisevich V; Fears AC; Agans KN; Deer DJ; Prasad AN; O'Toole R; Foster SL; Dobias NS; Geisbert JB; Fenton KA; Cross RW; Geisbert TW
    J Clin Invest; 2023 Feb; 133(3):. PubMed ID: 36445779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease.
    Prescott J; DeBuysscher BL; Feldmann F; Gardner DJ; Haddock E; Martellaro C; Scott D; Feldmann H
    Vaccine; 2015 Jun; 33(24):2823-9. PubMed ID: 25865472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters.
    van Doremalen N; Lambe T; Sebastian S; Bushmaker T; Fischer R; Feldmann F; Haddock E; Letko M; Avanzato VA; Rissanen I; LaCasse R; Scott D; Bowden TA; Gilbert S; Munster V
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007462. PubMed ID: 31170144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model.
    de Wit E; Feldmann F; Cronin J; Goldin K; Mercado-Hernandez R; Williamson BN; Meade-White K; Okumura A; Callison J; Weatherman S; Rosenke R; Avanzato VA; Lovaglio J; Scott DP; Marzi A; Feldmann H
    EBioMedicine; 2023 Jan; 87():104405. PubMed ID: 36508878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Lethal Aerosol Exposure Model of Nipah Virus Strain Bangladesh in African Green Monkeys.
    Prasad AN; Agans KN; Sivasubramani SK; Geisbert JB; Borisevich V; Mire CE; Lawrence WS; Fenton KA; Geisbert TW
    J Infect Dis; 2020 May; 221(Suppl 4):S431-S435. PubMed ID: 31665351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.
    Bossart KN; Rockx B; Feldmann F; Brining D; Scott D; LaCasse R; Geisbert JB; Feng YR; Chan YP; Hickey AC; Broder CC; Feldmann H; Geisbert TW
    Sci Transl Med; 2012 Aug; 4(146):146ra107. PubMed ID: 22875827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody.
    Geisbert TW; Mire CE; Geisbert JB; Chan YP; Agans KN; Feldmann F; Fenton KA; Zhu Z; Dimitrov DS; Scott DP; Bossart KN; Feldmann H; Broder CC
    Sci Transl Med; 2014 Jun; 6(242):242ra82. PubMed ID: 24964990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys.
    Geisbert JB; Borisevich V; Prasad AN; Agans KN; Foster SL; Deer DJ; Cross RW; Mire CE; Geisbert TW; Fenton KA
    J Infect Dis; 2020 May; 221(Suppl 4):S414-S418. PubMed ID: 31665362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses in mice and pigs after oral vaccination with rabies virus vectored Nipah disease vaccines.
    Shuai L; Ge J; Wen Z; Wang J; Wang X; Bu Z
    Vet Microbiol; 2020 Feb; 241():108549. PubMed ID: 31928698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates.
    Zeitlin L; Cross RW; Woolsey C; West BR; Borisevich V; Agans KN; Prasad AN; Deer DJ; Stuart L; McCavitt-Malvido M; Kim DH; Pettitt J; Crowe JE; Whaley KJ; Veesler D; Dimitrov A; Abelson DM; Geisbert TW; Broder CC
    Sci Transl Med; 2024 Apr; 16(741):eadl2055. PubMed ID: 38569014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
    Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
    Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhabdovirus-based vaccine platforms against henipaviruses.
    Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
    J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity.
    Prasad AN; Woolsey C; Geisbert JB; Agans KN; Borisevich V; Deer DJ; Mire CE; Cross RW; Fenton KA; Broder CC; Geisbert TW
    J Infect Dis; 2020 May; 221(Suppl 4):S436-S447. PubMed ID: 32022850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.